RCEL AVITA Medical Inc
Price (delayed)
$10.07
Market cap
$265.42M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.39
Enterprise value
$296.46M
AVITA Medical is a regenerative medicine company with a technology platform positioned to address unmet medical needs in burns, chronic wounds, and aesthetics indications. AVITA Medical's patented and proprietary collection
Highlights
The gross profit has grown by 26% year-on-year and by 7% since the previous quarter
The revenue has grown by 25% YoY and by 7% from the previous quarter
AVITA Medical's equity has shrunk by 91% YoY and by 63% QoQ
The net income has plunged by 75% YoY and by 8% from the previous quarter
Key stats
What are the main financial stats of RCEL
Market
Valuations
Earnings
Shares outstanding
26.36M
Market cap
$265.42M
Enterprise value
$296.46M
Price to earnings (P/E)
N/A
Price to book (P/B)
58.68
Price to sales (P/S)
4.06
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.61
Revenue
$64.25M
Gross profit
$55.16M
Operating income
-$56.59M
Net income
-$61.85M
EBIT
-$56.43M
EBITDA
-$54.46M
Free cash flow
-$58.11M
Per share
Balance sheet
Liquidity
EPS
-$2.39
EPS diluted
-$2.39
Free cash flow per share
-$2.25
Book value per share
$0.17
Revenue per share
$2.48
TBVPS
$2.86
Total assets
$79.71M
Total liabilities
$74.97M
Debt
$45.09M
Equity
$4.5M
Working capital
$36.84M
Debt to equity
10.02
Current ratio
2.83
Quick ratio
2.37
Net debt/EBITDA
-0.57
Margins
Efficiency
Dividend
EBITDA margin
-84.8%
Gross margin
85.8%
Net margin
-96.3%
Operating margin
-88.1%
Return on assets
-71.5%
Return on equity
-337.9%
Return on invested capital
-58.3%
Return on capital employed
-94.8%
Return on sales
-87.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
RCEL stock price
How has the AVITA Medical stock price performed over time
Intraday
1.82%
1 week
9.34%
1 month
7.36%
1 year
21.33%
YTD
-21.33%
QTD
23.71%
Financial performance
How have AVITA Medical's revenue and profit performed over time
Revenue
$64.25M
Gross profit
$55.16M
Operating income
-$56.59M
Net income
-$61.85M
Gross margin
85.8%
Net margin
-96.3%
The net income has plunged by 75% YoY and by 8% from the previous quarter
RCEL's net margin is down by 40% year-on-year
The operating income has contracted by 33% YoY but it has grown by 3.9% from the previous quarter
The gross profit has grown by 26% year-on-year and by 7% since the previous quarter
Growth
What is AVITA Medical's growth rate over time
Valuation
What is AVITA Medical stock price valuation
P/E
N/A
P/B
58.68
P/S
4.06
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.61
The company's EPS has shrunk by 71% YoY and by 7% QoQ
The stock's price to book (P/B) is 95% more than its last 4 quarters average of 29.6
AVITA Medical's equity has shrunk by 91% YoY and by 63% QoQ
The P/S is 64% below the 5-year quarterly average of 11.2 and 26% below the last 4 quarters average of 5.4
The revenue has grown by 25% YoY and by 7% from the previous quarter
Efficiency
How efficient is AVITA Medical business performance
The return on assets has dropped by 88% year-on-year and by 18% since the previous quarter
AVITA Medical's return on equity has shrunk by 74% QoQ
The company's return on sales fell by 32% YoY
The ROIC has contracted by 18% from the previous quarter but it has grown by 3.3% YoY
Dividends
What is RCEL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for RCEL.
Financial health
How did AVITA Medical financials performed over time
The total assets is 6% greater than the total liabilities
RCEL's quick ratio has dropped by 68% year-on-year and by 26% since the previous quarter
AVITA Medical's current ratio has shrunk by 64% YoY and by 24% QoQ
RCEL's debt to equity has soared by 169% since the previous quarter
AVITA Medical's equity has shrunk by 91% YoY and by 63% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.